Influence of Specialty and Clinical Experience on Treatment Sequencing in the Multimodal Management of Soft Tissue Extremity Sarcoma
Authors:
- Nabil WasifNWNabil Wasif
- Robert M. TamurianRTRobert M. Tamurian
- Scott ChristensenSCScott Christensen
- Ly DoLDLy Do
- Steve R. MartinezSMSteve R. Martinez
- Steven L. ChenSCSteven L. Chen
- Robert J. CanterRCRobert J. Canter
- 16 July 2011
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 19 (2) , 504-510
Abstract
Although multimodal management of extremity soft tissue sarcoma (STS) is the standard of care, considerable variation exists in the sequencing of radiotherapy (RT) or chemotherapy (CT). Our goal was to identify factors responsible for this variation. Members of specialty societies with an interest in STS were emailed a questionnaire about multimodal treatment of STS. Survey responses were scored on a 5-point Likert scale (1 = always preoperative and 5 = always postoperative) and analyzed by specialty, years in practice, and percentage of practice consisting of STS. The questionnaire was completed by 320 (65%) of 490 physicians, including medical oncologists (18%), radiation oncologists (8%), orthopedic oncologists (22%), surgical oncologists (45%), and others (7%). Respondents were evenly split on the use of neoadjuvant RT (mean 3.03 ± 0.06) and showed a slight preference for neoadjuvant CT (2.89 ± 0.06). Radiation oncologists (2.52 ± 0.18), physicians with a >75% STS practice (2.58 ± 0.17), and those in practice 75% STS practice (2.51 ± 0.16). Factors influencing the choice for neoadjuvant RT were well-defined treatment volume, increased acute morbidity, and decreased late morbidity, while for CT, they were in-situ disease monitoring and early treatment of micrometastases. Treatment sequencing in STS is influenced by specialty and clinical experience, with no clear consensus. These patterns may reflect the recent trend toward regionalization of STS care.Keywords
This publication has 12 references indexed in Scilit:
- Role of chemotherapy in the management of soft tissue sarcomasExpert Review of Anticancer Therapy, 2010
- Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomasEuropean Journal of Cancer, 2010
- Survey of ASCO Members on Management of Sentinel Node Micrometastases in Breast Cancer: Variation in Treatment Recommendations According to SpecialtyAnnals of Surgical Oncology, 2009
- Chemotherapeutic Management of Soft Tissue SarcomaSurgical Clinics of North America, 2008
- The Role of Radiation Therapy in the Management of SarcomasSurgical Clinics of North America, 2008
- Should Soft Tissue Sarcomas Be Treated at High-volume Centers?Annals of Surgery, 2007
- Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcomaRadiotherapy and Oncology, 2005
- Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trialThe Lancet, 2002
- Variable management of soft tissue sarcoma: Regional audit with implications for specialist careBritish Journal of Surgery, 1997
- The Treatment of Soft-tissue Sarcomas of the ExtremitiesAnnals of Surgery, 1982